February 27, 2018 / 1:44 PM / 3 months ago

BRIEF-Precision Therapeutics Forms Tumorgenesis Subsidiary

Feb 27 (Reuters) - Precision Therapeutics Inc:

* PRECISION THERAPEUTICS FORMS TUMORGENESIS INC. SUBSIDIARY TO FOCUS ON THE NEXT GENERATION OF PATIENT DERIVED TUMOR MODELS

* ‍FORMED TUMORGENESIS TO DEVELOP A NEW, RAPID APPROACH TO GROWING TUMORS IN LABORATORY​

* ‍TESTING OF TUMORGENESIS PDX TUMORS TO TAKE PLACE IN COLLABORATION WITH HELOMICS, IN WHICH CO HAS 20% EQUITY STAKE​

* IN NEGOTIATIONS WITH MEDICAL TECHNOLOGY COS TO LICENSE THEIR TECHNOLOGY TO ADVANCE TUMORGENESIS’S STRATEGIC PLAN​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below